Imunon (IMNN) CEO Stacy Lindborg receives stock grant instead of cash salary

Rhea-AI Filing Summary

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. President and CEO Stacy Lindborg received an equity grant of 2,534 shares of common stock at $1.91 per share in lieu of a portion of base salary. After this compensation-related award, she holds 76,722 shares directly and 778 shares indirectly through a 401(k) plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lindborg Stacy

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,534	$1.91	$5K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 76,722 shares (Direct, null); Common Stock — 778 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant shares: 2,534 shares Grant price: $1.91 per share Direct holdings after grant: 76,722 shares +1 more

4 metrics

Stock grant shares 2,534 shares Common Stock granted in lieu of salary

Grant price $1.91 per share Price used for the 2,534-share award

Direct holdings after grant 76,722 shares Common Stock directly owned after transaction

Indirect 401(k) holdings 778 shares Common Stock held indirectly via 401(k) plan

Key Terms

Form 4, grant in lieu of cash, indirect ownership, 401(k) Plan, +1 more

5 terms

Form 4 regulatory

"What did Imunon (IMNN) CEO Stacy Lindborg report in this Form 4?"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

grant in lieu of cash financial

"Stock granted in lieu of cash for portion of base salary"

indirect ownership financial

"Indirect holdings are reported as 778 Imunon common shares held through a 401(k) plan."

401(k) Plan financial

"She also has 778 shares held indirectly through a 401(k) plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

grant, award, or other acquisition financial

"code A transaction, described as a grant or award"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 04:56 PM Accepted by SEC EDGAR 07/07/2026 - 04:56 PM Learn about SEC filing dates

FAQ

What did Imunon (IMNN) CEO Stacy Lindborg report in this Form 4?

Stacy Lindborg reported receiving 2,534 Imunon common shares as a stock grant. The shares were awarded at $1.91 per share in lieu of a portion of her base salary, reflecting compensation rather than an open-market purchase or sale.

How many Imunon (IMNN) shares does Stacy Lindborg hold after this transaction?

After the reported grant, Stacy Lindborg holds 76,722 Imunon common shares directly. She also has 778 shares held indirectly through a 401(k) plan, giving visibility into her total reported equity exposure following this compensation-related transaction.

Was the Imunon (IMNN) CEO transaction a market purchase or a compensation grant?

The transaction was a compensation grant, not a market purchase. The Form 4 shows a code A transaction, described as a grant or award, with 2,534 shares granted in lieu of a portion of Stacy Lindborg’s base salary at $1.91 per share.

What price per share was used for Stacy Lindborg’s Imunon (IMNN) stock grant?

The stock grant used a price of $1.91 per Imunon common share. This price is disclosed as the transaction price per share for the 2,534-share award that was granted in lieu of a portion of her base salary compensation.

Does the Imunon (IMNN) Form 4 show any stock sales by Stacy Lindborg?

The Form 4 does not show any stock sales by Stacy Lindborg. It reports one acquisition of 2,534 shares as a grant in lieu of salary and a separate 401(k) holding entry, with no sale transactions indicated in the summarized data.

How are Stacy Lindborg’s indirect Imunon (IMNN) holdings reported?

Indirect holdings are reported as 778 Imunon common shares held through a 401(k) plan. This line is classified as indirect ownership and marked as a holding entry, showing the number of shares attributed to retirement-plan ownership after the reported date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindborg Stacy

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		A		2,534(1)	A	$1.91	76,722	D
Common Stock								778	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

	/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)